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 CURRENTOPINION Exercise for all cystic fibrosis patients: is the
evidence strengthening?
Helge Hebestreita, Susi Kriemlerb, and Thomas Radtkeb
Purpose of review
Regular physical activity and exercise have become important components of cystic fibrosis care. This
review summarizes the recent evidence in favour of regular exercise in cystic fibrosis that has accumulated
over the past years.
Recent findings
Several recently published small randomized-controlled trials and observational studies have added to our
knowledge on positive effects of exercise training on pulmonary function and aerobic fitness in cystic
fibrosis. Relevant outcomes, such as body posture, health-related quality of life and rate of hospitalization,
are increasingly studied. Findings from these studies suggest that exercise might also be beneficial for
these outcomes. So far, many important questions such as the best way of integrating exercise in cystic
fibrosis care and the determination of the optimal strategies for training and motivation remain mostly
unanswered.
Summary
Over the past years, evidence for the beneficial effects of regular exercise on lung health and aerobic
exercise capacity is strengthening. Despite the fact that most of the knowledge is based on small studies,
the observed effects are encouraging and there is no reason why exercise should not be implemented in all
patients’ care.
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INTRODUCTION
Over the last 20–30 years, regular physical activity
and exercise have been increasingly recommended
for people with cystic fibrosis. This recommen-
dation is based on beneficial effects of exercise
in the general population, some evidence from
smaller randomized-controlled trials and longi-
tudinal studies that found maximal aerobic
capacity to be one of the strongest predictors of
mortality in cystic fibrosis, and from a few studies
on potential mechanisms underlying the beneficial
effects of exercise on cystic fibrosis (pulmonary)
disease.
This review will summarize the evidence that
has accumulated over the past years in favour of
regular exercise in cystic fibrosis while highlighting
the most intriguing findings. Some of these studies
have addressed novel outcomes and/or augmented
our understanding of how exercise might lead to
improved lung function.
HOW MUCH EVIDENCE IS THERE THAT
REGULAR EXERCISE IMPROVES FITNESS
AND PULMONARY FUNCTION?
Evidence from randomized-controlled
exercise interventions
ACochrane systematic database reviewon the effects
of physical training for cystic fibrosis published in
2008 concluded that there was some limited evi-
dence for beneficial effects of physical exercise on
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exercise capacity, strength and lung functions based
on seven randomized-controlled studies [1
&
]. Since
then, several relatively small randomized-controlled
trials usingdifferent approaches havebeenpublished
[2
&
,3
&
,4–6]. The studies by Hebestreit et al. [2
&
] and
Kriemler et al. [3
&
] both assessed effects of physical
training over 6 months and reported improvements
in aerobic exercise capacity (expressed as peak oxy-
gen uptake, VO2peak) and lung functions in the
intervention compared with the control group. In
two studies from Santana-Sosa et al. [4,5] an 8-week
supervised aerobic and strength-training programme
including inspiratory muscle training in one study
resulted in improvements in VO2peak and muscle
strength. Likewise, a home-based aerobic and
strength training programme over 3 months did
result in improved upper limb strength [6]. In two
other studies fromaBrazilian group, the intervention
was based on manuals with instructions on home-
based aerobic and strength training given topatients.
One study observed changes in posture and the other
study found improvedmuscle strength but no effects
on aerobic exercise capacity or lung function [7,8].
Additional evidence from observational
studies in cystic fibrosis
Although large randomized-controlled trials on the
effects of physical exercise training in cystic fibrosis
are still lacking, observational studies may supple-
ment the evidence available from smaller trials.
Schneiderman et al. [9
&&
] followed 212 young patients
with cystic fibrosis over 9 years. In this sample, a
greater increase in reported habitual physical activity
was associated with a slower decline in forced expir-
atory volume in 1 s (FEV1) (1.63% per year) after
adjusting for sex, baseline age and FEV1, mucoid
Pseudomonas aeruginosa and cystic fibrosis-related
diabetes. The group of patients with an increase in
activity above average had an annual loss in FEV1 of
1.39% compared with 1.90% in those whose change
in activity was below average. In another study, Col-
laco et al. [10
&
] analyzed data from more than 1000
participants of theU.S.CFTwinSibling study. Regular
exercise participation was assessed by questionnaires
at baseline and subsequent rate of decline in FEV1was
calculated from repeated measurements. In a mixed
model analysis, adjusting for age at diagnosis, age at
assessment of exercise habits, sex and baseline FEV1,
regular exercise was associatedwith a reduced decline
in FEV1 and body mass index (BMI) z-score in adults.
However, for children aged 10–17 years at baseline,
no such association was detected, suggesting that
regular exercise may possibly be more important for
cystic fibrosis patients with advanced disease.
IS THERE EVIDENCE FOR ‘THE BEST’
EXERCISE MODE, DURATION AND
INTENSITY IN CYSTIC FIBROSIS?
Most randomized-controlled trials in the past
focussed on aerobic-type activities for intervention.
The randomized-controlled trial reported by Kriem-
ler et al. [3
&
] assessed the effects of 6months of either
aerobic or strength training compared with no
additional exercise training in mostly adult people
with cystic fibrosis. Interestingly, both aerobic train-
ing and strength training were associated with
similar improvements in FEV1, forced vital capacity
(FVC), and aerobic exercise capacity. Thus, both
training modes might be regarded as similarly effec-
tive in cystic fibrosis. However, in a separate publi-
cation of the same study assessing the longitudinal
associations between physical fitness and health-
related quality of life (HRQoL), strength training
had a negative effect on the scale ‘Vitality’ [11
&
].
Furthermore, strength training lowered static hyper-
inflation, whereas aerobic training did not. Kriemler
et al. [3
&
] speculated that improvements in FVC with
strength training might be because of a decrease in
hyperinflation in this group.
In people with cystic fibrosis and severe pul-
monary impairment, standard exercise training
might not be feasible. Gruber et al. [12] could show
that an individual interval-training programme on
the treadmill with supplemental oxygen five times
per week over a period of 6 weeks can improve
submaximal and maximal aerobic exercise capacity
in patients with severe disease (mean FEV1
25.57.5% predicted comparable to improvements
with conventional exercise training in patients
with less severe disease (mean FEV1 31.64.2%
predicted). These data support the fact that even
patients with severe lung impairment can benefit
from an individually tailored exercise intervention.
Theoptimal exercise training intensity forpeople
with cystic fibrosis remains to be defined.Most of the
KEY POINTS
 Exercise improves aerobic exercise capacity and
probably lowers the rate of decline in
pulmonary function.
 Motivation for exercise and long-term adherence to
regular training and sufficient habitual physical activity
remain major challenges in cystic fibrosis care.
 High-quality randomized controlled studies with long-
term follow-up are needed to increase the evidence
base for the effects of exercise on bone health,
exacerbations and cystic fibrosis-related diabetes.
Cystic fibrosis
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training studies that were able to improve aerobic
exercise capacity used moderate exercise intensities
at 50%ofVO2maxor60–85%ofmaximumheart rate
[2
&
,3
&
,4,5]. Recently, Wheatley et al. [13
&
] evaluated
the acute effects of exercise versus pharmacological
treatment with albuterol on diffusion capacity and
bronchodilation in mildly affected cystic fibrosis
patients by the use of different exercise intensities
(low, moderate and vigorous). Light intensity exer-
cisedidnot result in changesofdiffusioncapacitynor
inanydegreeofbronchodilation.Vigorous exercise –
although showing the highest increase in diffusion
capacity for nitric oxide – was associatedwith airflow
restriction. Moderate intensity exercise, however,
was found to be the optimal training intensity for
individuals with cystic fibrosis. Fifteen minutes of
moderate intensity exercise on a stationary bike lead
to a doubling of diffusion capacity of nitric oxide and
a relevant bronchodilation (þ23%) compared with
baseline. Albuterol administration induced a similar
bronchodilation 1–2h after application, but no
change in diffusion capacity.
DOES REGULAR EXERCISE IMPROVE
HEALTH-RELATED QUALITY OF LIFE?
In cystic fibrosis, VO2peak is a major determinant of
HRQoL and positively correlates with several
HRQoL scales [11
&
]. Likewise, improvements in
VO2peak are associated with a better health percep-
tion and less weight problems [11
&
]. Thus, it is not
surprising that all randomized-controlled studies on
exercise training in cystic fibrosis published recently
assessed HRQoL as important patient-reported out-
come [2
&
,3
&
,4–7]. Surprisingly, only one of these
studies was able to identify significant improve-
ments in HRQoL scales with physical training after
6 months of intervention [2
&
], while many others
lasting 2–6 months were not [4–7]. Several reasons
may contribute to the absence of effects on HRQoL.
First, exercise capacity did not change in some stud-
ies [6,7] indicating that the exercise intervention
may not have been of a sufficient intensity. In two
studies [4,5], HRQoL was analyzed as summary score
of all domains, whichmay have obscured the effects
of exercise on single HRQoL scales. It has been
shown that the associations between exercise
capacity and HRQoL are not of equal strength
among the different scales [11
&
].
ARE THERE EFFECTS OF REGULAR
EXERCISE ON BODY POSTURE?
Recently, Schindel et al. [8] investigated the effects
of physical training on posture. A manual with
instructions for aerobic exercises and stretching
was provided to a group of patients and recommen-
dations were reinforced by telephone calls every 2
weeks. After 3 months, the intervention group
showed a decrease in cervical lordosis, thoracic
kyphosis, lumbar lordosis, lateral chest distance
and abdominal protrusion compared with the con-
trol group using a photographic method that was
analyzed with commercial software.
DOES PHYSICAL TRAINING REDUCE THE
NEED FOR INTRAVENOUS ANTIBIOTICS
AND/OR THE NUMBER OF
HOSPITALIZATIONS?
Respiratory exacerbations are one of the most com-
mon reasons for hospitalizations in cystic fibrosis.
Perez et al. [14] investigated the associationsVO2peak
and risk for hospitalization in 77 children (104
years) with mild-to-moderate cystic fibrosis lung dis-
ease over 3 years. Thirty-one percent of the partici-
pantswere hospitalized oncewith amean in-hospital
stay of 104 days. In univariate Cox regression
analysis, FEV1, FVC and VO2peak and oxygen satur-
ation (SaO2) at peak exercise were associated with an
increased risk of hospitalization. In a multivariate
regression model, VO2peak remained the only inde-
pendent predictor of hospitalization. In line with
these findings, Urquhart et al. [15] reported a
reduction in days on intravenous antibiotics with a
supervised exercise programme in a small sample of
children with cystic fibrosis followed longitudinally,
yet, their study had no control group. As these
observed associations between physical fitness and
rate of hospitalization do not imply a causal relation-
ship, it has to be determined in the future whether
improvements in fitness through regular exercise can
result in fewerexacerbations, lesshospital admissions
or less need for intravenous antibiotics.
IS REGULAR EXERCISE EQUALLY
EFFECTIVE FOR EVERYBODY?
Age, sex, nutritional status, pulmonary impairment
or the types of mutation have a known impact on
the responses to regular exercise and physical train-
ing. However, there is some evidence that people
with high serum immunoglobulin (Ig) G levels and
colonization with Pseudomonas aeruginosa improved
VO2peak less than other patients performing regular
exercise [16].
NOVEL THERAPIES AND EFFECTS ON
EXERCISE CAPACITY
In recent years, advances have been made in novel
mutation-specific therapies in cystic fibrosis. After
Exercise for all cystic fibrosis patients Hebestreit et al.
1070-5287 Copyright  2015 Wolters Kluwer Health, Inc. All rights reserved. www.co-pulmonarymedicine.com 593
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
the first of these drugs – ivacaftor – became avail-
able to patients with at least one G551D mutation
and severely impaired pulmonary function, patients
reported an improved fitness shortly after the treat-
mentwas started [17]. Three cases were published on
the effects of ivacaftor on aerobic exercise capacity
in patients with F508del/G551D mutations [18,19].
Quon et al. [18] evaluated the effects of twice-daily
ivacaftor treatment (150 g) over 10 weeks in a male
adult with severe cystic fibrosis lung disease (FEV1
39% predicted). After ivacaftor treatment, FEV1 and
lung diffusion capacity for carbon monoxide (CO)
improved by 16 and 22%, respectively, and amarked
increase was observed in exercise duration, peak
workrate and VO2peak by 33, 25 and 14%, respect-
ively. The main reason for this striking improve-
mentwas thought to be attained through impressive
improvements in bronchial wall thickening and
mucus plugging visualized by computer tomogra-
phy (CT) scan that translated in improved venti-
lation with reduced expiratory flow limitations
at exercise. In another study, Saynor et al. [19]
reported on the effects of ivacaftor treatment in
two teenagers with cystic fibrosis and preserved lung
function (FEV1, 92 and 108% predicted) over 20
weeks. Cardiopulmonary exercise testing on a cycle
ergometer was performed 6 and 12 weeks after
initiation of treatment. After 12 weeks, improve-
ments in VO2peak were 30% in one patient, whereas
no meaningful change was observed in the other
patient. The latter patient, however, did not perform
maximally during 12-week postassessment. The
improvement of exercise capacity in the first patient
was associated with improved oxygen delivery and
muscle oxygen extraction resulting in increased
cardiac output, whereas cardiac output remained
unchanged in the second patient. Whether an
improved aerobic exercise capacity with ivacaftor
therapy can be observed in most patients receiving
this treatment, whether improvements merely
reflect changes in ventilation and pulmonary func-
tion and whether ivacaftor treatment modulates
training responses will require systematic studies.
APPROACHES AND CHALLENGES TO
IMPROVE PARTICIPATION AND
ADHERENCE TO PHYSICAL EXERCISE
Motivating people to become or to stay physically
active is sometimes challenging, not only in cystic
fibrosis. A recent Cochrane review evaluated the
effect of treatment to increase participation in
physical activity in cystic fibrosis and came to the
conclusion that there is very limited evidence that
activity counselling and exercise advice are effective
to promote participation in physical activity [20].
However, only few randomized-controlled studies
have addressed this relevant outcome.
Video game activities are becoming increasingly
popular and recent research has evaluated whether
these ‘new’ modalities can be considered as altern-
atives to conventional exercise training [21–23].
Active video games were well tolerated in one study
[23] and comparable with vigorous physical activity
in adults [21] and light-to-moderate physical
activity in children with cystic fibrosis [22]. How-
ever, whether these modalities have the potential to
sustain beneficial effects on aerobic fitness and
improve training adherence in the long-term
remains highly speculative based on rather disillu-
sioning results in health populations.
Further, in a small study, Cox et al. [24] eval-
uated an 8-week internet-based programme to
monitor and encourage participation in physical
activity in adults with cystic fibrosis. The pro-
gramme was found to be feasible and acceptable;
however, further data are needed to assess the use-
fulness of internet-based applications and apps to
increase physical activity participation in the long
term.
FUTURE PERSPECTIVES
Although physical activity and regular exercise are
advocated by most cystic fibrosis centres, many
questions still remain unanswered today: What is
the optimal training mode, duration and intensity
for people with cystic fibrosis? What is the optimal
setting and approach to motivate patients for life-
long exercise? And does exercise affect outcomes
other than fitness and pulmonary function? Lately,
the largest exercise trial ever performed in cystic
fibrosis, the international multicentre random-
ised-controlled study ACTIVATE-CF (clinical.trials.-
gov; NCT01744561), has started and will probably
be able to increase the current knowledge and evi-
dence base on the effects of exercise training in
people with cystic fibrosis. There is a clear need
for high-quality randomized-controlled studies with
sufficient numbers of patients and well chosen,
objectively measurable, reproducible and sensitive
outcome measures. These should include also rarely
studied but patient-relevant outcomes such as bone
health, diabetic control and exacerbations.
CONCLUSION
Over the past years, exercise training has become an
accepted and valued component of cystic fibrosis
care. Unfortunately, well-conducted prospective
randomized-controlled exercise training studies
are still rare in cystic fibrosis, and longer term
Cystic fibrosis
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follow-up although widely considered important is
rarely done. Future studies should not only focus on
the main intervention effects, but also on studying
the mediating mechanisms and potential modera-
tors, or subgroup effects, although we acknowledge
that cystic fibrosis is a rare disease. Only then canwe
start to answer the question: ‘For whom, how and
under what circumstances does which intervention
work?’ Despite the fact that there is substantial
heterogeneity on the effects of exercise training
between studies, the evidence is strengthening that
regular exercise can slow the rate of decline in
pulmonary function, improve aerobic exercise
capacity and possibly enhance HRQoL.
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